galactose has been researched along with acyclovir in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassi, B; Busi, C; Faulstich, H; Fiume, L; Mattioli, A; Spinosa, G | 1 |
| Chen, ZC; Lin, XF; Wu, Q; Zhang, F; Zhang, M | 1 |
| Agarwal, A; Agrawal, GP; Agrawal, H; Gupta, NK; Gupta, S; Saraogi, G | 1 |
| Attia, IA; Donia, AM; El-Gizawy, SA; Fouda, MA | 1 |
| Goto, M; Kamiya, N; Moniruzzaman, M; Tahara, Y; Tamura, M | 2 |
| Goto, M; Kamiya, N; Moniruzzaman, M | 1 |
| Kumar, A; Paul, S; Sawant, K; Yedurkar, P | 1 |
| Rajpoot, K | 1 |
| Abd-Elsalam, WH; Ibrahim, RR | 1 |
10 other study(ies) available for galactose and acyclovir
| Article | Year |
|---|---|
Galactosylated poly(L-lysine) as a hepatotropic carrier of 9-beta-D-arabinofuranosyladenine 5'-monophosphate.
Topics: Acyclovir; Animals; Arabinonucleotides; DNA; Galactose; Liver; Mice; Pharmaceutical Vehicles; Polylysine; Serum Albumin; Vidarabine Phosphate | 1986 |
Hepatic-targeting microcapsules construction by self-assembly of bioactive galactose-branched polyelectrolyte for controlled drug release system.
Topics: Acyclovir; Animals; Biocompatible Materials; Capsules; Delayed-Action Preparations; Drug Delivery Systems; Electrolytes; Galactose; Humans; Lectins; Liver; Receptors, Cell Surface | 2008 |
Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir.
Topics: Acyclovir; Animals; Antiviral Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Female; Galactose; Glycolates; Hemolysis; Lactic Acid; Liver; Male; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tissue Distribution | 2013 |
Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Biological Availability; Chemistry, Pharmaceutical; Cholesterol; Delayed-Action Preparations; Drug Compounding; Hexoses; Liposomes; Male; Organophosphates; Particle Size; Rabbits; Solubility; Technology, Pharmaceutical | 2007 |
Ionic liquid-assisted transdermal delivery of sparingly soluble drugs.
Topics: Acyclovir; Administration, Cutaneous; Animals; Drug Delivery Systems; Hexoses; Ionic Liquids; Polysorbates; Water | 2010 |
Ionic liquid-in-oil microemulsion as a potential carrier of sparingly soluble drug: characterization and cytotoxicity evaluation.
Topics: Acyclovir; Administration, Cutaneous; Animals; Drug Carriers; Drug Stability; Emulsifying Agents; Emulsions; Female; Hexoses; Humans; Ionic Liquids; Myristates; Particle Size; Permeability; Polysorbates; Skin; Skin Irritancy Tests; Solubility; Swine; Swine, Miniature | 2010 |
Ionic liquid based microemulsion with pharmaceutically accepted components: Formulation and potential applications.
Topics: Acyclovir; Emulsions; Hexoses; Ionic Liquids; Methotrexate; Myristates; Particle Size; Pharmaceutical Preparations; Polysorbates; Solubility; Surface Properties; Surface-Active Agents | 2010 |
Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir.
Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Biological Availability; Chemical Phenomena; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Drug Storage; Emulsions; Excipients; Hexoses; Hydrophobic and Hydrophilic Interactions; Male; Particle Size; Polyethylene Glycols; Rats; Surface-Active Agents; Viscosity | 2013 |
Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization.
Topics: Acyclovir; Animals; Antiviral Agents; Biological Transport; Drug Carriers; Drug Compounding; Drug Liberation; Emulsions; Esters; Gels; Hexoses; Hydrogen-Ion Concentration; Kinetics; Myristates; Permeability; Phase Transition; Rheology; Skin; Swine; Tissue Culture Techniques; Viscosity | 2017 |
Span 80/TPGS modified lipid-coated chitosan nanocomplexes of acyclovir as a topical delivery system for viral skin infections.
Topics: Acyclovir; Chitosan; Drug Carriers; Drug Delivery Systems; Hexoses; Lipids; Nanoparticles; Particle Size; Vitamin E | 2021 |